Karolinska Development: Changes at the top
Following the resignation of erstwhile CEO Jim Van heusden, Karolinska Development has promoted Viktor Drvota to the position of head of the company. Drvota held the position of Chief Investment Officer before.
Drvota joined Karolinska Development in February 2016 and was promoted Deputy Chief Executive Officer in March 2017. He brings more than 15 years of life science investment experience. Prior to joining Karolinska Development he worked at SEB Venture Capital, where he was Head of Life Science from 2002 and a senior investment manager. Before joining SEB, Viktor was a practicing cardiologist at Huddinge University Hospital in Stockholm. He has been an Associate Professor in Cardiology at Karolinska Institutet, Stockholm, since 2002.
Van heusden is formally leaving KDev at the end of October 2017.
Bo Jesper Hansen, Chairman of the Board since 2013, also announced his departure. He informed the company that he would not stand for re-election this year.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium